abbott-neuromodulation
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Medication-free neurostimulation technology, FDA approved for Diabetic Peripheral Neuropathy, MRI Conditional systems, patient stories, and a focus on improving movement and feeling for chronic conditions.
Description Brand's website · 2026-10-04
Abbott Neuromodulation provides technology and therapies, including Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS), to help people living with chronic pain, Parkinson’s disease, and essential tremor move and feel better. Their solutions are often medication-free and aim to improve daily life for patients with movement disorders and chronic pain, including FDA-approved treatments for Diabetic Peripheral Neuropathy.
Offerings
Core capabilities Brand's website · 2026-10-04
- Neurostimulation therapies
- Eterna™ SCS System
- Proclaim™ SCS Family
- Deep Brain Stimulation (DBS)
- BurstDR™ stimulation therapy.
Pricing Brand's website · 2026-10-04
Not specified, likely B2B sales to healthcare providers with insurance reimbursement for patients.
Audience
Target industry Brand's website · 2026-10-04
Individuals living with chronic pain (including Diabetic Peripheral Neuropathy), Parkinson’s disease, and essential tremor; healthcare providers treating these conditions.
Is this your business?
The information above is publicly sourced — assembled by Optimly from abbott-neuromodulation's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for abbott-neuromodulation across the index.
Claim abbott-neuromodulation — free →Page last updated 2026-10-17.